Urine Proteome of Surgical Patients and Healthy Volunteers.

Washington University School of Medicine1 site in 1 country664 target enrollmentFebruary 2012

ConditionsRenal Cell Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Renal Cell Cancer
Sponsor: Washington University School of Medicine
Enrollment: 664
Locations: 1
Primary Endpoint: evaluation of novel bio markers
Status: Completed
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to define early urinary biomarkers for diagnosis and prognosis of Renal Cell Carcinoma (RCC) with subsequent development of reliable, cost-effective, screening techniques.

Registry

clinicaltrials.gov

Start Date

February 2012

End Date

July 2016

Last Updated

7 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Washington University School of Medicine

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•18 years and older
•Planned procedure with presumptive diagnosis of RCC, bladder or prostate cancer OR control patient undergoing non-urological surgery OR normal healthy volunteer OR post surgical patient with a diagnosis of RCC and under surveillance for reoccurrence of RCC or treatment of metastatic RCC
•Signed, informed consent

Exclusion Criteria

•Patients on dialysis

Outcomes

Primary Outcomes

evaluation of novel bio markers

Time Frame: 5 years

The overall objective of our study is to find and evaluate additional novel biomarkers, predictive of disease, that are present and measurable in whole urine of patients undergoing surgery for renal cancer.